UCSF

ZINC03871978

Substance Information

In ZINC since Heavy atoms Benign functionality
October 4th, 2005 29 No

Other Names:

(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-3-[(carbamoyloxy)methyl]-7-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 55268-75-2; CPD0-2069; cefuroxime

(6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefuroxim; Cefuroxime; Cephuroxime

(6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester)

(6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester); 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-f

153012-39-6

3-[(carbamoyloxy)methyl]-7beta-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-3,4-didehydrocepham-4-carboxylic acid

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt (6R-(6alpha,7beta(Z)))-

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt (6R-(6alpha,7beta(Z)))-; Anaptivan; Biociclin; Bioxima; C16H15N4O8S.Na; CEFUROXIME; CEFUROXIME AND DEXTR

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methyoxyimino)acetyl)amino)-8-oxo-, (6R-(6-alpha,7-beta(Z)))-

55268-75-2

56238-63-2

56238-63-2; C08108; Cefuroxime sodium

56238-63-2; CXM; Cefuroxime sodium (JAN/USP); D00915; Zinacef (TN)

640/359

AC-15028

AC-4539

AC1NUIFB

AC1Q41FS

Anaptivan

Ancef

BIDD:GT0619

Biociclin

Biofuroksym

Bioxima

BPBio1_001033

BRD-K02733959-236-02-8

BRN 5783190

BSPBio_000939

C06894

C08108

C16H15N4O8S.Na

C16H16N4O8S

C4417_FLUKA

C4417_SIGMA

Cedax

cef-

Cefizox

Cefobid

Cefofix

Cefotan

Ceftin

Cefumax

Cefurax

Cefurex

Cefuril

Cefuroxim

Cefuroxim AJ

Cefuroxim curasan

Cefuroxim Fresenius

Cefuroxim Genericsn

Cefuroxim Hexal

Cefuroxim Lilly

Cefuroxim MN

Cefuroxim Norcox

Cefuroxim Norcox [inj.]

Cefuroxim;Cefuroxime [USAN:BAN:INN];Cefuroximo [INN-Spanish];Cefuroximum [INN-Latin]

Cefuroxima Fabra

Cefuroxima Richet

Cefuroxime

Cefuroxime (BAN

Cefuroxime (sodium)

Cefuroxime (TN)

Cefuroxime (USAN/INN)

CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER

Cefuroxime for Injection and Dextrose for Injection in Duplex Container

cefuroxime na

Cefuroxime Sodium (BAN

Cefuroxime sodium (JP15/USP)

Cefuroxime sodium salt

Cefuroxime sodium [USAN:BAN:JAN]

Cefuroxime [USAN:BAN:INN]

Cefuroxime [USAN:INN:BAN]

Cefuroxime, Antibiotic for Culture Media Use Only

cefuroxime; cefuroximo; cefuroximum

cefuroximesodium

Cefuroximine

Cefuroximo

Cefuroximo [INN-Spanish]

Cefuroximum

Cefuroximum [INN-Latin]

Cefzil

Cepazine

Cephuroxime

Cetroxil

Cetroxil [inj.]

CHEBI:3515

CHEMBL1436

CID5479529

CID6523269

Colifossim

CPD0-2069

CPD001496804; Cefuroxime; SAM002589901

Curocef

Curoxim

Curoxima

Curoxime

CXM

D00262

D00915

DAP000445

Duricef

EINECS 259-560-1

EINECS 260-073-1

Elobact

FDA

FDA); Cefuroxime Sodium (BAN

Froxal

Froxal [inj.]

Furoxil

INN

JAN

Kefurox

KEFUROX IN PLASTIC CONTAINER

Kefzol

Kerurox

Kesint

Ketocef

KS-1040

Lifurox

LS-149936

LS-2226

Mandol

Maxipime

Medoxim

Mefoxin

MFCD00864889

MFCD09878727

MolPort-002-885-814

MolPort-005-938-003

Monocid

Oraxim

Prestwick3_000720

Rocephin

Sharox

Sharox [inj.]

Sharox; Zinacef Danmark

Sodium (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), carbamate (ester)

Sodium (6R-(6alpha,7beta(Z)))-3-(((aminocarbonyl)oxy)methyl)-7-(2-furyl(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate

Sodium cefuroxime

Spectrazolr

Ultroxim

UNII-O1R9FJ93ED

UNII-R8A7M9MY61

USAN

USAN)

USP)

USP); Cefuroxime (BAN

Velosef

Zinacef

Zinacef (TN)

Zinacef Danmark

ZINACEF IN PLASTIC CONTAINER

Zinat

Zinnat

Zinnat [inj.]

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -0.98 2.31 -68.98 3 12 -1 177 423.383 8

Vendor Notes

Note Type Comments Provided By
MP 176 - 178 Enamine Building Blocks
MP 176...178 Enamine Building Blocks
ALOGPS_SOLUBILITY 2.84e-01 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 98% APIChem
Indications antibiotic KeyOrganics Bioactives
Patent Database Links EP1359153; EP1452533; EP1702921; EP1724273; EP1815846; EP1829527; EP1829528; GB2157565; US2006235023; US2006258636; US2007202051; US2007202077; US2007212340; US2008255073; US2008255200; WO2005009948; WO2005020894; WO2006005137; WO2007089745; WO2007100902 ChEBI
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Enamine; NCC_SUPPLIER_STRUCTURE_ID : 241392054 NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Enamine; SUPPLIER_STRUCTURE_ID: 241392054 NIH Clinical Collection via PubChem

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )